The Chinese-German Journal of Clinical Oncology

, 10:502

The experimental research on the inhibiting impacts of RNAi on Cyclin E in breast cancer cell line

Authors

  • Xueqin Li
    • Thyroid and Breast Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology
  • Na Shen
    • Thyroid and Breast Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology
    • Thyroid and Breast Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology
  • Tao Huang
    • Thyroid and Breast Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology
Article

DOI: 10.1007/s10330-011-0833-4

Cite this article as:
Li, X., Shen, N., He, W. et al. Chin. -Ger. J. Clin. Oncol. (2011) 10: 502. doi:10.1007/s10330-011-0833-4
  • 40 Views

Abstract

Objective

The aim of the study was to investigate the biological character change of breast cancer cell line by inhibiting the Cyclin E expressing level.

Methods

Human breast cancer cell line MCF-7 was transfected by Cyclin E siRNA vector pEGFP/CCNE2. SiRNA-induced silencing of Cyclin E was determined at RNA level and protein level, respectively. The proliferation of MCF-7 and its sensitivity to chemical therapy were measured by CCK-8 assay, while cell cycle was measured by flow cytometry (FCM).

Results

The plasmid could reduce the expression of Cyclin E. The proliferation ability of MCF-7 was decreased and the sensitivity to chemical therapy was enhanced according to the inhibition of Cyclin E expression. The transfected MCF-7 was arrested at G1 phase of cell cycle.

Conclusion

The inhibition of Cyclin E can decrease the breast cancer cell’s growth, increase its sensation to chemical therapy and slow down its cell cycle. The Cyclin E siRNA may provide us a practical tool for further study on the gene therapy to breast cancers.

Key words

breast cancerCyclin ERNAi

Copyright information

© Springer-Verlag Berlin Heidelberg 2011